Skip to main content

Table 2 Cell cycle in LNCaP cells

From: SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo

Cell cycle phase

Control

DHT

SFRP1

SFRP1 + DHT

Nocodazole

G1

75.6% ± 0.2

73.05% ± 2.2

77.21% ± 0.5

71.95% ± 3.1

79.31% ± 0.2

S

9.0% ± 0.1

12.04% ± 3.2

7.66% ± 0.3

12.76% ± 2.4

7.36% ± 0.2

G2

15.3% ± 0.3

14.91% ± 1.1

15.12% ± 0.1

15.29% ± 1.6

13.34% ± 0.07

  1. Data are the average ± s.d. of a representative experiment carried out in triplicate (*p < 0.005; Student’s t-test, of treatments compared to control (vehicle)